PICCOLO trial met its primary endpoint of objective response rate (ORR) Data from the study will be presented at a future medical meeting NORTH CHICAGO, Ill., June 6, 2024 /PRNewswire/ — AbbVie (NYSE: ABBV) announced today positive topline results from the Phase 2 PICCOLO trial…

The rise of Chinese suppliers will change the game CAMPBELL, Calif., June 6, 2024 /PRNewswire/ — Mobile Experts released its definitive report on the Radio Frequency Front End market for smartphones today, including clear predictions about the future direction of shipments and revenue…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.